Skip To Main Content
Bridget E. Barber on Muck Rack

Bridget E. Barber

As seen in: Nature, Wiley Online Library, The Conversation, Science Magazine, BioRxiv, The Lancet, Medical Journal of Australia (MJA), Medicine Today
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bridget E.

Contact Bridget E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria

|
By Kyeongseok Jeon, Axel A Guzmán-Solís, Rory Malek, Bridget E. Barber, Robin Denhardt-Eriksson, Etienne Guirou, Julia Flynn, Nischal Sahai, Indika Leelasena, Susan Mathison, Chris Moller, Ivan Lim, Carla Evangelista, Rebecca Webster, Adam Potter, Stacey Llewellyn, Fiona Amante, Jeremy Gower, David Khoury, Vandana Thathy, Sunil K Narwal, Tomas Yeo, David A Fidock, Michael Marx
| Science Magazine Verified
Editor’s summary Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations View Options References Figures Tables Media Share Editor’s summary The pyrrolidinamide drug MMV367 has been tested preclinically as an antimalarial. Barber et al.
Open in Who Shared Issue with article?

The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria

|
By Bridget E. Barber, Robin Denhardt-Eriksson, Etienne Guirou
| mmv.org
Bridget E. Barber, Robin Denhardt-Eriksson, Etienne A. Guirou, Julia Flynn, Nischal Sahai, Indika Leelasena, Susan Mathison, Chris Moller, Ivan Lim, Carla Evangelista, Rebecca Webster, Adam J. Potter, Stacey Llewellyn, Fiona H. Amante, Jeremy Gower, Jenny Peters, David S. Khoury, Vandana Thathy, Sunil K. Narwal, Tomas Yeo, David A. Fidock, Michael W. Marx, Francisco-Javier Gamo, Raman Sharma, Rachel A.
Open in Who Shared Issue with article?

Age is an intrinsic driver of inflammatory responses to malaria - Nature Communications

|
By Nicholas L. Dooley, J. Alejandro López, Kim A Piera, Bridget E. Barber, Matthew J Grigg, Gabriela Minigo
| Nature Verified
Abstract Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. We assessed inflammatory cytokines during malaria in non-immune children and adults, and innate cell responses in vitro to malaria parasites in naive children and adults.
Open in Who Shared Issue with article?
See all 14 articles